G261D (p.Gly261Asp) variant of GLA (Alpha-galactosidase A)
G261D (p.Gly261Asp) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes published literature and structural context.
G261D (p.Gly261Asp) variant details
- p.Gly261Asp
- rs869312401
- ClinGen CA413923937
- ClinVar RCV001255564
- UniProt VAR 012414
- Pathogenic
- Fabry disease
- Missense
- Variant Prioritization Score for Impact Estimate 0.84
- AlphaMissense 0.49
- MetaLR 0.99
- MetaSVM 0.93
- PolyPhen-2 1.00
- SIFT 0.08
- EVE 0.77
- ClinVar: Pathogenic (Fabry disease)
- EBI: Pathogenic (in FABRYD)
- UniProt: Pathogenic (in FABRYD)
- Structural context available
- Cited in: Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography. (PMID 15712228)
- Cited in: Screening and detection of gene mutations in Japanese patients with Fabry disease by non-radioactive single-stranded… (PMID 9105656)